ReSTOR IOL good in post LASIK cataract patients

Article

The use of the ReSTOR intraocular lens (IOL) (Alcon) for patients requiring cataract surgery after prior laser photoablation can result in excellent outcomes if optical results fall near emmetropia, according to Samuel Masket of the USA.

The use of the ReSTOR intraocular lens (IOL) (Alcon) for patients requiring cataract surgery after prior laser photoablation can result in excellent outcomes if optical results fall near emmetropia, according to Samuel Masket of the USA.

A total of 16 eyes of 11 patients were chosen to receive the lens after discussing thoroughly the risks, benefits and alternative lens options. Presurgical biometry was performed by partial coherence interferometry and appropriate formulae applied for IOL power calculation.

Surgery was performed using topical and intracameral anaesthesia employing phacoemulsification through clear corneal temporal incisions. Five patients underwent bilateral surgery while the remaining six required surgery in just one eye.

The results showed that all five bilateral patients were fully independent of spectacles after surgery and that, in all, ten of the eleven patients were very satisfied with the visual outcomes. One patient was moderately dissatisfied despite achieving 20/25 and J2+ uncorrected visual acuities. There were no complications of surgery and no IOLs were removed or exchanged.

Masket concluded that the ReSTOR IOL offers a good option for patients needing cataract surgery after laser photoablation.

Ophthalmology Times Europe reporting from the XXIV Congress of the ESCRS, London, 9-13 September, 2006.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.